Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Growth · Riverpark

Riverpark/Next Century Growth Fund Institutional Class Shares (RPNIX)

Ticker RPNIX · · Holdings as of Jun 30, 2026

Expense ratio
1.15%$115/yr per $10k
1-yr return
+7.7%as of Dec 2025
Net assets
$12.1Mall share classes
Holdings
56

Bottom line

Is RPNIX a good fund? The bottom line

RPNIX is the Institutional Class share class of Riverpark/Next Century Growth Fund, a managed large growth mutual fund from Riverpark.

Annual fees run 1.15% — about $115 a year on every $10,000 invested, more expensive than 74% of large growth funds we track.

It returned +7.7% over one year (as of Dec 31, 2025, per its prospectus).

With $12.1 million in net assets and 56 holdings, its largest position is Xometry, Inc. (4.4%) and the top 10 make up 32.5% of the portfolio.

What to watch

  • Expensive for its category (1.15%)
  • Small fund ($12.1 million) — small funds are likelier to close

Updated Nov 19, 2026

What RPNIX invests in

The RiverPark/Next Century Growth Fund (Next Century Growth or the Fund) seeks long-term capital appreciation through investments primarily in securities of small-cap companies.

The Fund, under normal market conditions, invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of small cap companies. The Fund defines small cap companies as those with market capitalizations, at the time of initial investment, of less than the market capitalization of the largest company in the Russell 2000 Index on a rolling three-year basis. As of December 31, 2025, the market capitalization of the largest company in the Russell 2000 Index on a rolling three-year basis was $59.1 billion. The Fund seeks to achieve its investment objective by investing in companies that the Funds sub-adviser, Next Century Growth Investors, LLC (Next Century or the Sub-Adviser), believes will sustain above-average revenue and earnings growth over time, or which are expected to develop rapid sales and earnings growth in the future when compared to…

From the fund's prospectus (filed Feb 2, 2026).

RPNIX performance

Fund calendar-year total returns, 2024–2025 2024: +17.1%; 2025: +7.6% +17.1% 2024 +7.6% 2025
Fund gain (+)
Average annual total returns
1 yr5 yr10 yr
RPNIX+7.7%——
Large Growth median+15.2%+11.0%+14.2%

Source: Fund prospectus, as of Dec 31, 2025

Full RPNIX performance history →

What RPNIX costs

On a $10,000 investment, RPNIX's 1.15% expense ratio costs about $115 a year. The prospectus estimates $1,842 in total costs over 10 years (assuming 5% annual returns). The median large growth fund charges 0.87%.

See the full RPNIX fee table →

RPNIX top 10 holdings

#Holding% of fund
1Xometry, Inc.4.38%
2Astronics Corporation3.58%
3Ligand Pharmaceuticals Incorporated3.57%
4Alignment Healthcare, Inc.3.52%
5N/a3.24%
6Knight-swift Transportation Holdings Inc.3.05%
7Lincoln Educational Services Corporation3.02%
8Mirum Pharmaceuticals, Inc.2.77%
9Forgent Power Solutions, Inc.2.72%
10Saia, Inc.2.64%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 32.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to RPNIX

More funds like RPNIX →

RPNIX FAQ

What is the expense ratio of RPNIX?
RPNIX's expense ratio is 1.15%, which works out to about $115 a year for every $10,000 invested. The prospectus estimates total costs of $1,842 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is RPNIX a good investment?
It depends on your goals, but the data points to: expensive for its category (1.15%); small fund ($12.1 million) — small funds are likelier to close. This is general information, not personalized advice.
What does RPNIX hold?
RPNIX's largest holdings are Xometry, Inc. (4.4%), Astronics Corporation (3.6%), Ligand Pharmaceuticals Incorporated (3.6%), Alignment Healthcare, Inc. (3.5%), N/a (3.2%). It holds 56 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Who manages RPNIX?
RPNIX is offered by Riverpark through Riverpark Funds Trust.